Vaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: a randomised trial.

ABSTRACT:

Background

Cervical cancer screening coverage remains insufficient in most countries. Our objective was to assess whether in-home vaginal self-sampling with a dry swab for high-risk human papillomavirus (HR-HPV) testing is effective and cost-effective in increasing participation in cervical cancer screening.

Methods

In March 2012, 6000 unscreened women aged 30-65 years, living in a French region covered by a screening programme, who had not responded to an initial invitation to have a Pap smear were equally randomised to three groups: 'no intervention'; 'recall', women received a letter to have a Pap smear; and 'self-sampling', women received a self-sampling kit to return to a centralised virology laboratory for PCR-based HPV testing.

Results

Participation was higher

SUBMITTER: Haguenoer K 

PROVIDER: S-EPMC4260034 | biostudies-literature | 2014 Nov

REPOSITORIES: biostudies-literature